2Quock J, Dea G, Lim N, Tanaka M,Gandara D,Lau D. PremedicationStrategy for Weekly Paclitaxel Based on Experience with 1,608 Infusions of 3-and 4-Week Paclitaxel (Meeting abstract). Proc Annu Meet Am Soc Clin Oncol, 1999, 18: A635.
4Gennari A, Salvadori B, Tognoni A, Conte PF. Rapid intravenous premedication with dexamethasone prevents hypersensitivityreactions to paclitaxel. Ann Oncol, 1996, 7 (9): 978～979.
5Parikh B, Khanolkar S, Advani SH, Dhabhar B, Chandra M. Safety profile of single-dose dexamethasone premedication for paclitaxel. J ClinOncol, 1996, 14 (7): 2189～2190.
7Yamada Y, Shirao K, Ohtsu A, Boku N, Hyodo I, Saitoh H, Miyata Y, Taguchi T. Phase Ⅱ trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions. Ann Oncol, 2001, 12 (8): 1133～1137.
8Koppler H, Heymanns J, Weide R. Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions. Onkologie, 2001, 24 (3): 283～285.
9Christodoulou C,Klouvas G,Pateli A.Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer[J].Anticancer Res,2003,23(1B):737.
10Gennari A,Guarneriv,Landucci E.Weelky docetaxel/paclitaxel in pre2 treated metastatic breast cancer[J].Clin Breast Cancer,2002,3(5):346-352.
